Lutz Joachimsen
Overview
Explore the profile of Lutz Joachimsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joachimsen L, Farassat N, Bleul T, Bohringer D, Lagreze W, Reich M
Int Ophthalmol
. 2021 Feb;
41(6):2001-2008.
PMID: 33634343
Purpose: Based on findings of the Asian low-concentration atropine for myopia progression study, a concentration of 0.05% has been proposed as a good compromise between safety and efficacy for myopia...
2.
Kuechlin S, Steiert C, Naseri Y, Joachimsen L, Gruber M, Reich M, et al.
World Neurosurg
. 2021 Jan;
149:e1007-e1016.
PMID: 33476778
Objective: The choice of surgical technique in sight-threatening Grave orbitopathy remains controversial. Available data are mostly derived from mixed cohorts with multiple surgical indications and techniques. The authors assessed predictors...
3.
Reich M, Lubke J, Joachimsen L, Stifter J, Kuchlin S, Bohringer D, et al.
Graefes Arch Clin Exp Ophthalmol
. 2020 Nov;
259(6):1521-1528.
PMID: 33185728
Purpose: To evaluate peripapillary retinal nerve fibre layer (RNFL) thickness measured by spectral domain optical coherence tomography (OCT) in patients with Stargardt disease (STGD). Methods: A cross-sectional, monocentric, observational case-control...
4.
Dreesbach M, Joachimsen L, Kuchlin S, Reich M, Gross N, Brandt A, et al.
Transl Vis Sci Technol
. 2020 Aug;
9(3):24.
PMID: 32742754
Purpose: Idiopathic intracranial hypertension (IIH) leads to optic nerve head swelling and optic atrophy if left untreated. We wanted to assess an easy to perform volumetric algorithm to detect and...
5.
Kuchlin S, Gruber M, Reich M, Joachimsen L, Metzger M, Beck J, et al.
Ophthalmologe
. 2020 Jul;
118(4):345-355.
PMID: 32681301
Background: Graves' orbitopathy is the most frequent extrathyroidal manifestation of Graves' disease, affecting approximately 25-50% of patients. It leads to inflammation and swelling of orbital soft tissues. The treatment is...
6.
Nickels S, Blom H, Schulz A, Joachimsen L, Munzel T, Wild P, et al.
PLoS One
. 2020 Apr;
15(4):e0231011.
PMID: 32282799
Purpose: There is a strong association between severe hyperhomocysteinemia and myopia. Thus we studied the hypothesis that even moderately increased levels of homocysteine (Hcy) might be a potentially treatable risk...
7.
Lang S, Joachimsen L, Stifter J, Reich M, Kuchlin S, Bohringer D, et al.
Klin Monbl Augenheilkd
. 2020 Feb;
237(8):985-989.
PMID: 32016941
Background: The treatment of tumors increasingly takes place in specialised interdisciplinary centres. Therapeutic decisions are usually made at case conferences. Ophthalmologists, oromaximillofacial surgeons, ENT physicians, neurosurgeons, as well as pediatricians,...
8.
Reich M, Glatz A, Cakir B, Bohringer D, Lang S, Kuchlin S, et al.
BMJ Open Ophthalmol
. 2019 Dec;
4(1):e000318.
PMID: 31799409
Objective: To describe vascular changes in different stages of Stargardt disease (STGD) via double swept-source optical coherence tomography angiography. Methods And Analysis: Prospective, cross-sectional case-control study. Twenty-three patients (45 eyes)...
9.
Joachimsen L, Bohringer D, Gross N, Reich M, Stifter J, Reinhard T, et al.
Ophthalmol Ther
. 2019 Jun;
8(3):427-433.
PMID: 31190219
Introduction: Although the interest is growing in topical low-dose atropine to control myopia in schoolchildren worldwide, its use in children of European ancestry remains controversial and solid evidence is sparse....
10.
Anders L, Heinrich S, Lagreze W, Joachimsen L
Doc Ophthalmol
. 2019 Jan;
138(2):85-95.
PMID: 30680489
Purpose: Daily administration of 0.01% atropine eye drops is a promising approach for myopia control. The mechanism of action is believed to involve the dopaminergic system of the retina, triggering...